R&D Systems Recombinant Mouse CD19 Fc Chimera Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9730CD050
DescriptionThe Recombinant Mouse CD19 Fc Chimera Protein is derived from CHO. The Recombinant Mouse CD19 Fc Chimera Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<1.0 EU per 1μg of the protein by the LAL method.|
|B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, Leu-12, MGC12802, T-cell surface antigen Leu-12|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Reconstitute at 500μg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok